🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies

RecruitingNAAges 1 Day - 5 DaysAllKonya City Hospital
NCT06880016 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Infants of families who agree to participate in the study * Preterm infants born before 32 weeks of gestation requiring surfactant therapy due to an RDS diagnosis. Exclusion Criteria: * Infants whose families did not provide consent * Infants with a syndromic appearance or congenital heart disease * Preterm infants born after 32 weeks of gestation
💊

What it tests

  • Evaluation of serial lung ultrasound data after ENSURE surfactant treatments
  • Evaluation of serial lung ultrasound data after LISA surfactant treatments
📍

Where

1 site
Melek Buyukeren
Konya, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy